Gene · 8720
Papers2,858
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,858
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipid compartments and lipid metabolism as therapeutic targets against coronavirus. | Front Immunol | 2023 | 38106410 | PubTator, text mining | PubMed |
| Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic. | Front Med (Lausanne) | 2023 | 38089874 | PubTator, text mining | PubMed |
| Targeting the myeloid microenvironment in neuroblastoma. | J Exp Clin Cancer Res | 2023 | 38087370 | PubTator, text mining | PubMed |
| Editorial: Sepsis: studying the immune system to highlight biomarkers for diagnosis, prognosis and personalized treatments. | Front Immunol | 2023 | 38077361 | PubTator, text mining | PubMed |
| Interplay between Vitamin D and Sphingolipids in Cardiometabolic Diseases. | Int J Mol Sci | 2023 | 38069444 | PubTator, text mining | PubMed |
| Molecular Profiling of Lymphatic Endothelial Cell Activation In Vitro. | Int J Mol Sci | 2023 | 38068914 | PubTator, text mining | PubMed |
| Hyaluronic Acid Hydrogels with Phototunable Supramolecular Cross-Linking for Spatially Controlled Lymphatic Tube Formation. | ACS Appl Mater Interfaces | 2023 | 38065571 | PubTator, text mining | PubMed |
| Co-encapsulated astaxanthin and kaempferol nanoparticles: fabrication, characterization, and their potential synergistic effects on treating non-alcoholic fatty liver disease. | RSC Adv | 2023 | 38046630 | PubTator, text mining | PubMed |
| A review on the mechanisms underlying the antitumor effects of natural products by targeting the endoplasmic reticulum stress apoptosis pathway. | Front Pharmacol | 2023 | 38044941 | PubTator, text mining | PubMed |
| Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease. | Stem Cells Int | 2023 | 38034060 | PubTator, text mining | PubMed |
| New insights into the unfolded protein response (UPR)-anterior gradient 2 (AGR2) pathway in the regulation of intestinal barrier function in weaned piglets. | Anim Nutr | 2023 | 38033605 | PubTator, text mining | PubMed |
| An Exploration of Anti-Inflammatory Therapy in Acute/Subacute Severe Cerebral Venous Thrombosis with Hereditary Protein C/S Deficiency: Case Series. | J Inflamm Res | 2023 | 38026243 | PubTator, text mining | PubMed |
| Machine learning chained neural network analysis of oxygen transport amplifies the physiological relevance of vascularized microphysiological systems. | Bioeng Transl Med | 2023 | 38023704 | PubTator, text mining | PubMed |
| Advanced Progress in the Role of Adipose-Derived Mesenchymal Stromal/Stem Cells in the Application of Central Nervous System Disorders. | Pharmaceutics | 2023 | 38004615 | PubTator, text mining | PubMed |
| Secretome as a Tool to Treat Neurological Conditions: Are We Ready? | Int J Mol Sci | 2023 | 38003733 | PubTator, text mining | PubMed |
| Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis. | Gut Microbes | 2023 | 37979154 | PubTator, text mining | PubMed |
| Inflammatory macrophages reprogram to immunosuppression by reducing mitochondrial translation. | Nat Commun | 2023 | 37978290 | PubTator, text mining | PubMed |
| Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins. | Nat Commun | 2023 | 37963884 | PubTator, text mining | PubMed |
| Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-Cancer. | Int J Mol Sci | 2023 | 37958642 | PubTator, text mining | PubMed |
| Rhomboid protease RHBDL4/RHBDD1 cleaves SREBP-1c at endoplasmic reticulum monitoring and regulating fatty acids. | PNAS Nexus | 2023 | 37954160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8720/papers?page=15